324 related articles for article (PubMed ID: 17290298)
1. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?
Rommel C; Camps M; Ji H
Nat Rev Immunol; 2007 Mar; 7(3):191-201. PubMed ID: 17290298
[TBL] [Abstract][Full Text] [Related]
2. Phosphoinositide 3-kinase signalling in the vascular system.
Morello F; Perino A; Hirsch E
Cardiovasc Res; 2009 May; 82(2):261-71. PubMed ID: 19038971
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease.
Ito K; Caramori G; Adcock IM
J Pharmacol Exp Ther; 2007 Apr; 321(1):1-8. PubMed ID: 17021257
[TBL] [Abstract][Full Text] [Related]
4. Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.
Barberis L; Hirsch E
Thromb Haemost; 2008 Feb; 99(2):279-85. PubMed ID: 18278175
[TBL] [Abstract][Full Text] [Related]
5. Cardiac regulation by phosphoinositide 3-kinases and PTEN.
Oudit GY; Penninger JM
Cardiovasc Res; 2009 May; 82(2):250-60. PubMed ID: 19147653
[TBL] [Abstract][Full Text] [Related]
6. Phosphoinositide 3-kinase delta inhibitor as a novel therapeutic agent in asthma.
Park SJ; Min KH; Lee YC
Respirology; 2008 Nov; 13(6):764-71. PubMed ID: 18811876
[TBL] [Abstract][Full Text] [Related]
7. The pathophysiological roles of PI3Ks and therapeutic potential of selective inhibitors in allergic inflammation.
Takeda M; Ito W; Tanabe M; Ueki S; Kihara J; Kato H; Tanigai T; Kayaba H; Sasaki T; Chihara J
Int Arch Allergy Immunol; 2010; 152 Suppl 1():90-5. PubMed ID: 20523070
[TBL] [Abstract][Full Text] [Related]
8. PI3K isoforms as drug targets in inflammatory diseases: lessons from pharmacological and genetic strategies.
Harris SJ; Foster JG; Ward SG
Curr Opin Investig Drugs; 2009 Nov; 10(11):1151-62. PubMed ID: 19876783
[TBL] [Abstract][Full Text] [Related]
9. Phosphoinositide 3-kinase signalling and FoxO transcription factors in rheumatoid arthritis.
Reedquist KA; Ludikhuize J; Tak PP
Biochem Soc Trans; 2006 Nov; 34(Pt 5):727-30. PubMed ID: 17052183
[TBL] [Abstract][Full Text] [Related]
10. Leukocytes on the move with phosphoinositide 3-kinase and its downstream effectors.
Procko E; McColl SR
Bioessays; 2005 Feb; 27(2):153-63. PubMed ID: 15666353
[TBL] [Abstract][Full Text] [Related]
11. Phosphoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis?
Fougerat A; Gayral S; Malet N; Briand-Mesange F; Breton-Douillon M; Laffargue M
Clin Sci (Lond); 2009 May; 116(11):791-804. PubMed ID: 19397491
[TBL] [Abstract][Full Text] [Related]
12. Do phosphoinositide 3-kinases direct lymphocyte navigation?
Ward SG
Trends Immunol; 2004 Feb; 25(2):67-74. PubMed ID: 15102365
[TBL] [Abstract][Full Text] [Related]
13. The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications.
Weichhart T; Säemann MD
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii70-4. PubMed ID: 19022819
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease.
Marwick JA; Chung KF; Adcock IM
Ther Adv Respir Dis; 2010 Feb; 4(1):19-34. PubMed ID: 20051446
[TBL] [Abstract][Full Text] [Related]
15. The role of PI3K in immune cells.
Koyasu S
Nat Immunol; 2003 Apr; 4(4):313-9. PubMed ID: 12660731
[TBL] [Abstract][Full Text] [Related]
16. Cytokines in the pathogenesis of rheumatoid arthritis.
McInnes IB; Schett G
Nat Rev Immunol; 2007 Jun; 7(6):429-42. PubMed ID: 17525752
[TBL] [Abstract][Full Text] [Related]
17. Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity.
Paunovic V; Carroll HP; Vandenbroeck K; Gadina M
Rheumatology (Oxford); 2008 Jun; 47(6):771-6. PubMed ID: 18238793
[TBL] [Abstract][Full Text] [Related]
18. T-lymphocyte navigation and migration: beyond the PI3K paradigm.
Smith L; Webb A; Ward SG
Biochem Soc Trans; 2007 Apr; 35(Pt 2):193-8. PubMed ID: 17371236
[TBL] [Abstract][Full Text] [Related]
19. Isoform-selective PI3K inhibitors as novel therapeutics for the treatment of acute myocardial infarction.
Doukas J; Wrasidlo W; Noronha G; Dneprovskaia E; Hood J; Soll R
Biochem Soc Trans; 2007 Apr; 35(Pt 2):204-6. PubMed ID: 17371238
[TBL] [Abstract][Full Text] [Related]
20. Targeting signaling pathways with small molecules to treat autoimmune disorders.
Kaminska B; Swiatek-Machado K
Expert Rev Clin Immunol; 2008 Jan; 4(1):93-112. PubMed ID: 20477590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
